Jason Travis Curtis - 20 May 2026 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Jun 2026, 17:01:16 UTC
Prior SEC filing
28 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kate Venturina, as attorney-in-fact

Key filing fact

Jason Travis Curtis filed Form 4 for U S PHYSICAL THERAPY INC /NV (USPH) on 22 Jun 2026.

Key facts

  • This page summarizes Jason Travis Curtis's Form 4 filing for U S PHYSICAL THERAPY INC /NV (USPH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Jun 2026, 17:01.

Change

  • Previous filing in this sequence was filed on 28 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750716 Primary reporting owner

CURTIS JASON TRAVIS

Relationship
Interim CFO
Address
1300 W SAM HOUSTON PKWAY S, SUITE 300, HOUSTON
Signature
/s/ Kate Venturina, as attorney-in-fact
Signature date
22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

USPH transaction

Common Stock

Tax liability

Transaction value
Shares
-40
Change %
-1%
Price
$62.24*
Shares after
3,893
Date
20 May 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

Footnote F2

Includes 3,596 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 171 shares vest on each of August 20, 2026, November 20, 2026, and March 6, 2027; 1,250 shares vest on May 15, 2027; 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029; 178 shares vest on May 20, 2029; 93 shares vest on each of August 20, 2029 and November 20, 2029; and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date.

SEC remarks

This Form 4 is being filed late due to inadvertent administrative error.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .